A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer

1. Planchard, D.
2. Wolf, J.
3. Solomon, B.
4. Sebastian, M.
5. Wermke, M.
6. Heist, R.S.
7. Sun, J.-M.
8. Min Kim, T.
9. Reguart, N.
10. Sanmamed, M.F.
11. Felip, E.
12. Garrido, P.
13. Santoro, A.
14. Bootle, D.
15. Couillebault, X.-M.
16. Gaur, A.
17. Mueller, C.
18. Poggio, T.
19. Yang, J.
20. Moschetta, M.
21. Dooms, C.